Insights

Logistics by Design (LbD) is a framework for logistics decision making. Using a risk based analysis it identifies the areas within the supply chain that need to be addressed to create a logistics platform that can meet the needs of patients at clinical and commercial scale.

Every CEO will be able to describe their target patient population, their clinical capability and their strategy for developing a manufacturing process, but how many can describe their strategy for connecting all of this to the patient? That is, what is their logistics vision?

Take a look at the recent development of Cell and Gene Therapy and how this relatively new medical field will see patients benefiting for years to come.

Overcoming logistical challenges through technology

Specialist centres will create and deliver systems to progress advanced therapy development through joint ventures set up by industry, academic and NHS partners

Sam Herbert, President of World Courier, gives insight into how cell and gene therapies can present new and difficult challenges for manufacturers and what can be done to support manufacturers from a supply chain perspective

You’re investing hundreds of millions of dollars to develop products to enhance patient care and improve global health. But can your logistics partner meet the challenges?

The success of a clinical study depends on the CRO’s or sponsor’s ability to bring together people, processes, and technology in a coordinated effort to improve patient outcomes, one case at a time.

In this webinar on-demand World Courier’s Cell and Gene Therapy specialists share their knowledge with you, and discuss how our practical experience of Cell and Gene shipments is evolving logistics.

To help you understand why personalized therapies require a personalized supply chain, we’ve published Tomorrow’s Medicine: Curing One Patient at a Time – an e-book highlighting the logistics challenges of cell and gene therapies.